To validate the translational relevance of the uncovered ADAM10 upregulation, we analyzed ADAM10 expression in tissue lysates from patients with ischemic (ICM) and dilated cardiomyopathy (DCM) or non-failing hearts (NF). This evidence concerns the gene ADAM10 and dilated cardiomyopathy.